For instance, such subtypes could differ by the status of HER2, which is known to play an important role in breast cancer carcinogenesis [40] or statuses of other potential breast cancer biomarkers (such as Ki67, Cyclin D1, Estrogen Receptor β [53]). This evidence concerns the gene ERBB2 and breast carcinoma.